Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Neuroscience and Physiology / Inst för neurovetenskap och fysiologi >
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi >

Proteomic strategies for analysis of cerebrospinal fluid in neurodegenerative disorders

Please use this identifier to cite or link to this item:

Files in This Item:

File Description SizeFormat
ram skickad.pdfThesis frame1807KbAdobe PDF
Spikblad rättat 080316 .pdfAbstract25KbAdobe PDF
Title: Proteomic strategies for analysis of cerebrospinal fluid in neurodegenerative disorders
Authors: Hansson, Sara
Issue Date: 4-Apr-2008
University: University of Gothenburg. Sahlgrenska Academy
Institution: Inst of Neuroscience and Physiology. Dept of Psychiatry and Neurochemistry
Parts of work: I. Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients. Hansson SF, Puchades M, Blennow K, Sjogren M, Davidsson P. Proteome Sci. 2004 Nov 18;2(1):7.

II. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Puchades M*, Hansson SF*, Nilsson CL, Andreasen N, Blennow K, Davidsson P. Brain Res Mol Brain Res. 2003 Oct 21;118(1-2):140-6.

III. Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer’s disease patients. Hansson SF, Andreasson U, Wall M, Skoog I, Andreasen N, Wallin A, Zetterberg H, Blennow K. Submitted.

IV. Cystatin C in cerebrospinal fluid and multiple sclerosis. Hansson SF, Hviid Simonsen A, Zetterberg H, Andersen O, Haghighi S, Fagerberg I, Andreasson U, Westman-Brinkmalm A, Wallin A, Ruetschi U, Blennow K. Ann Neurol. 2007 Aug;62(2):193-6.

V. Characterization of tau in cerebrospinal fluid using mass Spectrometry. Portelius E*, Hansson SF*, Tran AJ, Zetterberg H, Grognet P, Vanmechelen E, Brinkmalm G, Westman-Brinkmalm A, Nordhoff E, Blennow K and Gobom J. J Proteome Res, in press 2008.
Disputation: Fredagen den 25 april 2008, kl. 13.00, Psykiatriklinikens aula (V-aulan), Sahlgrenska universitetssjukhuset/Mölndal
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: Alzheimer’s disease
frontotemporal dementia
cerebrospinal fluid
mass spectrometry
protein identification
Abstract: ABSTRACT There is a great need for biomarkers to diagnose neurodegenerative disorders, such as the cognitive disorders Alzheimer’s disease (AD) and frontotemporal dementia (FTD). Cerebrospinal fluid (CSF) is in contact with the extracellular fluid of the brain and is consequently a valuable medium for identifying biomarkers for neurological disorders. Biomarkers can be used for early identification of disease, to facilitate homogenous classification and to extend our basic knowledge of diseas... more
ISBN: 978-91-628-7422-3
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet



© Göteborgs universitet 2011